These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 22119740)

  • 1. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells.
    Kim K; Zhao R; Doi A; Ng K; Unternaehrer J; Cahan P; Huo H; Loh YH; Aryee MJ; Lensch MW; Li H; Collins JJ; Feinberg AP; Daley GQ
    Nat Biotechnol; 2011 Nov; 29(12):1117-9. PubMed ID: 22119740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation dynamics in human induced pluripotent stem cells over time.
    Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A
    PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic memory in induced pluripotent stem cells.
    Kim K; Doi A; Wen B; Ng K; Zhao R; Cahan P; Kim J; Aryee MJ; Ji H; Ehrlich LI; Yabuuchi A; Takeuchi A; Cunniff KC; Hongguang H; McKinney-Freeman S; Naveiras O; Yoon TJ; Irizarry RA; Jung N; Seita J; Hanna J; Murakami P; Jaenisch R; Weissleder R; Orkin SH; Weissman IL; Feinberg AP; Daley GQ
    Nature; 2010 Sep; 467(7313):285-90. PubMed ID: 20644535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states.
    Lee JH; Lee JB; Shapovalova Z; Fiebig-Comyn A; Mitchell RR; Laronde S; Szabo E; Benoit YD; Bhatia M
    Nat Commun; 2014 Dec; 5():5605. PubMed ID: 25465724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.
    Dorn I; Klich K; Arauzo-Bravo MJ; Radstaak M; Santourlidis S; Ghanjati F; Radke TF; Psathaki OE; Hargus G; Kramer J; Einhaus M; Kim JB; Kögler G; Wernet P; Schöler HR; Schlenke P; Zaehres H
    Haematologica; 2015 Jan; 100(1):32-41. PubMed ID: 25326431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.
    Petrova A; Capalbo A; Jacquet L; Hazelwood-Smith S; Dafou D; Hobbs C; Arno M; Farcomeni A; Devito L; Badraiq H; Simpson M; McGrath JA; Di WL; Cheng JB; Mauro TM; Ilic D
    Stem Cells Dev; 2016 Sep; 25(18):1366-75. PubMed ID: 27460132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.
    Vitaloni M; Pulecio J; Bilic J; Kuebler B; Laricchia-Robbio L; Izpisua Belmonte JC
    J Biol Chem; 2014 Jan; 289(4):2084-98. PubMed ID: 24311783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.
    Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC
    PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells.
    Wang J; Gu Q; Hao J; Bai D; Liu L; Zhao X; Liu Z; Wang L; Zhou Q
    Genomics Proteomics Bioinformatics; 2013 Oct; 11(5):304-11. PubMed ID: 24080286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining differentially methylated regions specific for the acquisition of pluripotency and maintenance in human pluripotent stem cells via microarray.
    He W; Kang X; Du H; Song B; Lu Z; Huang Y; Wang D; Sun X; Yu Y; Fan Y
    PLoS One; 2014; 9(9):e108350. PubMed ID: 25250679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells.
    Bar-Nur O; Russ HA; Efrat S; Benvenisty N
    Cell Stem Cell; 2011 Jul; 9(1):17-23. PubMed ID: 21726830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.
    Sommer CA; Christodoulou C; Gianotti-Sommer A; Shen SS; Sailaja BS; Hezroni H; Spira A; Meshorer E; Kotton DN; Mostoslavsky G
    PLoS One; 2012; 7(12):e51711. PubMed ID: 23272148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
    Gao X; Yourick JJ; Sprando RL
    Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
    Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
    Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.
    Li Y; Hong N; Zhang A; Chen W; Wang RH; Xu XL; Deng CX
    Cell Death Dis; 2014 Dec; 5(12):e1550. PubMed ID: 25476898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.